H56:IC31: Clinical Trials

6 trials of H56:IC31, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 withdrawn. 4 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Completed 4
Phase 22Completed 1, Withdrawn 1

Follow H56:IC31: new trials by email Literature Review of H56:IC31 trials Research Report on H56:IC31

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Evaluate H56:IC31 in Preventing Rate of TB Recurrence
H56:IC31, Placebo - Tuberculosis, Pulmonary
Phase 2CompletedInternational AIDS Vaccine Initiative8312019-01-312026-02-24
A Phase II Study of H56:IC31 in Healthy Adolescents
H56:IC31, Placebo - Tuberculosis Infection
Phase 2WithdrawnAeras2018-06-012018-04-10
Therapeutic Vaccination and Immune Modulation - New Treatment Strategies for the MDR Tuberculosis Pandemic
etoricoxib, H56:IC31 - Tuberculosis
Phase 1CompletedAnne Margarita Dyrhol Riise392015-11-012022-04-08
Safety and Immunogenicity Study of BCG, H4:IC31, and H56:IC31 Revaccination in Healthy Adolescents
H4:IC31, H56:IC31, BCG - Tuberculosis
Phase 1CompletedAeras842015-05-012019-11-18
A Phase I Study of Safety & Immunogenicity of AERAS-456 in HIV-Neg. Adults Treated for Drug-susceptible Pulmonary TB
H56:IC31, Placebo - Tuberculosis
Phase 1CompletedAeras222014-11-212024-07-30
Safety and Immunogenicity Study of AERAS-456 Vaccine for Tuberculosis
H56:IC31 - Latent Tuberculosis, Latent Tuberculosis Bacteriology and Histology Unknown
Phase 1CompletedAeras252011-11-012019-08-21

Conditions studied

Tuberculosis (4)  ·  Latent Tuberculosis (2)  ·  Recurrence (1)  ·  Reinfection (1)  ·  Tuberculosis, Pulmonary (1)

Sponsors

Aeras (4)  ·  Anne Margarita Dyrhol Riise (1)  ·  International AIDS Vaccine Initiative (1)

Countries

South Africa (5)  ·  Tanzania (2)  ·  Norway (1)

Top investigators

Angelique Luabeya, MD (1)  ·  Anne Margarita Dyrhol-Riise, PhD (1)  ·  Dereck Tait, MBChB (1)  ·  Dereck Tait, MD (1)  ·  Jim Kublin, MD (1)  ·  Linda-Gail Bekker, MD (1)  ·  Marissa Russell (1)

Results publications

PMID 30888024, PMID 32382714, PMID 34811370, PMID 37721470, PMID 40056922, PMID 42482138

NIH funding

2014 (1)